Antiretroviral medications as prevention: will the new paradigm reverse the HIV epidemic?

Keith Henry

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Abstract

Fifteen years after recognition of the AIDS epidemic, the development of potent antiretroviral therapy (ART) resulted in a significant reduction in HIV-related morbidity and mortality for persons in resource-rich regions of the world. Now 30 years after the HIV/AIDS epidemic began, we have learned that potent ART also decreases transmission of HIV and that judicious use of antiretroviral medications in people who do not have the virus but are at high risk for contracting it (pre-exposure prophylaxis or PREP) can protect against HIV infection. We now have the necessary tools to significantly decrease the scope of the epidemic in the decades ahead. Whether we use them-that is, provide antiretrovirals prophylactically or conduct widespread testing for HIV and treat all people who are found to have the virus-will depend on the concerted actions of societies, governments, public health authorities, clinicians and individuals.

Original languageEnglish (US)
Pages (from-to)48-50
Number of pages3
JournalMinnesota medicine
Volume95
Issue number8
StatePublished - Aug 2012

Fingerprint Dive into the research topics of 'Antiretroviral medications as prevention: will the new paradigm reverse the HIV epidemic?'. Together they form a unique fingerprint.

Cite this